InduPro was founded by K. Chris Garcia.

Who are InduPro's investors?

InduPro's investors include MRL Ventures Fund, The Column Group, Vida Ventures.

Where is InduPro headquartered?

InduPro is headquartered in Seattle, US.

InduPro

Seattle, US · 3 known investors

InduPro develops next-generation protein therapeutics by leveraging inherent and induced proximity to modulate disease biology, with a focus on ADCs and T-cell engagers. The company built proprietary platforms — Membrane Interactomics (MInt) for target discovery, ARRIS for proximity modalities using multi-specific antibody technology, and internal antibody discovery and engineering — to identify targets and design therapeutic molecules.

BiotechDeep TechMedical Devices

Founders & leadership

K. Chris GarciaScientific Founder

Prakash RamanCEO

Amanda J. RedigChief Medical Officer

Scott LesleyPresident & CSO

Pamela HollandSVP of Biology

Sally JohnsonChief People Officer

Investors · 3

MRL Ventures Fund✓ verifiedCambridge · $25M

The Column Group✓ verifiedSan Francisco · $30M

Vida Ventures✓ verifiedLos Angeles

Competitors · 2

by search overlap

Aro Biotherapeutics9 shared keywordsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.

Insitro8 shared keywordsinsitro is a drug discovery and development company that uses machine learning and cellular data to identify therapeutic insights and accelerate the creation of new medicines. The company serves patients and pharmaceutical development by integrating in vitro lab data with human clinical data to decode biology and unlock transformative treatments.

Companies competing with InduPro for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does InduPro do?: InduPro develops next-generation protein therapeutics by leveraging inherent and induced proximity to modulate disease biology, with a focus on ADCs and T-cell engagers. The company built proprietary platforms — Membrane Interactomics (MInt) for target discovery, ARRIS for proximity modalities using multi-specific antibody technology, and internal antibody discovery and engineering — to identify targets and design therapeutic molecules.
Who founded InduPro?: InduPro was founded by K. Chris Garcia.
Who are InduPro's investors?: InduPro's investors include MRL Ventures Fund, The Column Group, Vida Ventures.
Where is InduPro headquartered?: InduPro is headquartered in Seattle, US.